Influenza Vaccines Market Report

Europe Influenza Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 21, 2019
  • PAGES：212
  • REPORT CODE：GMM407022
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Influenza Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Influenza Vaccines Market Segmentations:

    By Player:

    • Vaccitech

    • Genentech

    • Green Cross

    • BionVax

    • Vaxart

    • SK Chemicals

    • UNM Pharma

    • Sanofi

    • CSL

    • Novavax

    • AstraZeneca

    • FOLIA BIOTECH

    • Altimmune

    • Moderna Therapeutics

    • GlaxoSmithKline

    • Shijiazhuang Yiling Pharmaceutical

    • Visterra

    • Medicago

    • FluGen

    • Vaxine Pty

    By Type:

    • Trivalent Flu Vaccines

    • Quadrivalent Flu Vaccines

    By End-User:

    • Adults

    • Pediatrics

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Influenza Vaccines Market Size and Growth Rate of Trivalent Flu Vaccines from 2014 to 2026

    • 1.3.2 Europe Influenza Vaccines Market Size and Growth Rate of Quadrivalent Flu Vaccines from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Influenza Vaccines Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.4.2 Europe Influenza Vaccines Market Size and Growth Rate of Pediatrics from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Influenza Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenza Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Trivalent Flu Vaccines

      • 3.4.2 Market Size and Growth Rate of Quadrivalent Flu Vaccines

    4 Segmentation of Influenza Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenza Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenza Vaccines for Adults

      • 4.4.2 Market Size and Growth Rate of Influenza Vaccines for Pediatrics

    5 Market Analysis by Major Regions

    • 5.1 Europe Influenza Vaccines Production Analysis by Top Regions

    • 5.2 Europe Influenza Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Influenza Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Influenza Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Influenza Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Influenza Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Influenza Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Influenza Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Influenza Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Influenza Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Influenza Vaccines Landscape Analysis

    • 7.1 Germany Influenza Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Influenza Vaccines Landscape Analysis by Major End-Users

    8. UK Influenza Vaccines Landscape Analysis

    • 8.1 UK Influenza Vaccines Landscape Analysis by Major Types

    • 8.2 UK Influenza Vaccines Landscape Analysis by Major End-Users

    9. France Influenza Vaccines Landscape Analysis

    • 9.1 France Influenza Vaccines Landscape Analysis by Major Types

    • 9.2 France Influenza Vaccines Landscape Analysis by Major End-Users

    10. Italy Influenza Vaccines Landscape Analysis

    • 10.1 Italy Influenza Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Influenza Vaccines Landscape Analysis by Major End-Users

    11. Spain Influenza Vaccines Landscape Analysis

    • 11.1 Spain Influenza Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Influenza Vaccines Landscape Analysis by Major End-Users

    12. Poland Influenza Vaccines Landscape Analysis

    • 12.1 Poland Influenza Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Influenza Vaccines Landscape Analysis by Major End-Users

    13. Russia Influenza Vaccines Landscape Analysis

    • 13.1 Russia Influenza Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Influenza Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Influenza Vaccines Landscape Analysis

    • 14.1 Switzerland Influenza Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Influenza Vaccines Landscape Analysis by Major End-Users

    15. Turkey Influenza Vaccines Landscape Analysis

    • 15.1 Turkey Influenza Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Influenza Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Influenza Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Influenza Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Influenza Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Influenza Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Influenza Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Influenza Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Influenza Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Influenza Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Influenza Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Influenza Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Influenza Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Vaccitech

      • 19.1.1 Vaccitech Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Genentech

      • 19.2.1 Genentech Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Green Cross

      • 19.3.1 Green Cross Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 BionVax

      • 19.4.1 BionVax Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Vaxart

      • 19.5.1 Vaxart Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 SK Chemicals

      • 19.6.1 SK Chemicals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 UNM Pharma

      • 19.7.1 UNM Pharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Sanofi

      • 19.8.1 Sanofi Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 CSL

      • 19.9.1 CSL Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Novavax

      • 19.10.1 Novavax Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 AstraZeneca

      • 19.11.1 AstraZeneca Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 FOLIA BIOTECH

      • 19.12.1 FOLIA BIOTECH Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Altimmune

      • 19.13.1 Altimmune Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Moderna Therapeutics

      • 19.14.1 Moderna Therapeutics Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 GlaxoSmithKline

      • 19.15.1 GlaxoSmithKline Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Shijiazhuang Yiling Pharmaceutical

      • 19.16.1 Shijiazhuang Yiling Pharmaceutical Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Visterra

      • 19.17.1 Visterra Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Medicago

      • 19.18.1 Medicago Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 FluGen

      • 19.19.1 FluGen Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Vaxine Pty

      • 19.20.1 Vaxine Pty Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 93 Figures and 131 Tables)

    • Figure Product Picture

    • Figure Europe Influenza Vaccines Market Size and Growth Rate of Trivalent Flu Vaccines from 2014 to 2026

    • Figure Europe Influenza Vaccines Market Size and Growth Rate of Quadrivalent Flu Vaccines from 2014 to 2026

    • Figure Europe Influenza Vaccines Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Europe Influenza Vaccines Market Size and Growth Rate of Pediatrics from 2014 to 2026

    • Figure Germany Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Influenza Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenza Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenza Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenza Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Influenza Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Trivalent Flu Vaccines

    • Figure Market Size and Growth Rate of Quadrivalent Flu Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenza Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenza Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Adults

    • Figure Market Size and Growth Rate of Pediatrics

    • Table Europe Influenza Vaccines Production by Major Regions

    • Table Europe Influenza Vaccines Production Share by Major Regions

    • Figure Europe Influenza Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Influenza Vaccines Consumption by Major Regions

    • Table Europe Influenza Vaccines Consumption Share by Major Regions

    • Table Germany Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table France Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Influenza Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Influenza Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Influenza Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Influenza Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table UK Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table France Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Influenza Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Vaccitech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaccitech

    • Figure Sales and Growth Rate Analysis of Vaccitech

    • Figure Revenue and Market Share Analysis of Vaccitech

    • Table Product and Service Introduction of Vaccitech

    • Table Company Profile and Development Status of Genentech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

    • Figure Sales and Growth Rate Analysis of Genentech

    • Figure Revenue and Market Share Analysis of Genentech

    • Table Product and Service Introduction of Genentech

    • Table Company Profile and Development Status of Green Cross

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross

    • Figure Sales and Growth Rate Analysis of Green Cross

    • Figure Revenue and Market Share Analysis of Green Cross

    • Table Product and Service Introduction of Green Cross

    • Table Company Profile and Development Status of BionVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BionVax

    • Figure Sales and Growth Rate Analysis of BionVax

    • Figure Revenue and Market Share Analysis of BionVax

    • Table Product and Service Introduction of BionVax

    • Table Company Profile and Development Status of Vaxart

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxart

    • Figure Sales and Growth Rate Analysis of Vaxart

    • Figure Revenue and Market Share Analysis of Vaxart

    • Table Product and Service Introduction of Vaxart

    • Table Company Profile and Development Status of SK Chemicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals

    • Figure Sales and Growth Rate Analysis of SK Chemicals

    • Figure Revenue and Market Share Analysis of SK Chemicals

    • Table Product and Service Introduction of SK Chemicals

    • Table Company Profile and Development Status of UNM Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UNM Pharma

    • Figure Sales and Growth Rate Analysis of UNM Pharma

    • Figure Revenue and Market Share Analysis of UNM Pharma

    • Table Product and Service Introduction of UNM Pharma

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Novavax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

    • Figure Sales and Growth Rate Analysis of Novavax

    • Figure Revenue and Market Share Analysis of Novavax

    • Table Product and Service Introduction of Novavax

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of FOLIA BIOTECH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FOLIA BIOTECH

    • Figure Sales and Growth Rate Analysis of FOLIA BIOTECH

    • Figure Revenue and Market Share Analysis of FOLIA BIOTECH

    • Table Product and Service Introduction of FOLIA BIOTECH

    • Table Company Profile and Development Status of Altimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune

    • Figure Sales and Growth Rate Analysis of Altimmune

    • Figure Revenue and Market Share Analysis of Altimmune

    • Table Product and Service Introduction of Altimmune

    • Table Company Profile and Development Status of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Shijiazhuang Yiling Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shijiazhuang Yiling Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shijiazhuang Yiling Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shijiazhuang Yiling Pharmaceutical

    • Table Product and Service Introduction of Shijiazhuang Yiling Pharmaceutical

    • Table Company Profile and Development Status of Visterra

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Visterra

    • Figure Sales and Growth Rate Analysis of Visterra

    • Figure Revenue and Market Share Analysis of Visterra

    • Table Product and Service Introduction of Visterra

    • Table Company Profile and Development Status of Medicago

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago

    • Figure Sales and Growth Rate Analysis of Medicago

    • Figure Revenue and Market Share Analysis of Medicago

    • Table Product and Service Introduction of Medicago

    • Table Company Profile and Development Status of FluGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FluGen

    • Figure Sales and Growth Rate Analysis of FluGen

    • Figure Revenue and Market Share Analysis of FluGen

    • Table Product and Service Introduction of FluGen

    • Table Company Profile and Development Status of Vaxine Pty

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxine Pty

    • Figure Sales and Growth Rate Analysis of Vaxine Pty

    • Figure Revenue and Market Share Analysis of Vaxine Pty

    • Table Product and Service Introduction of Vaxine Pty

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US